China NMPA Inspection - Nanjing Hongan Medical Technology Co., Ltd. - May 09, 2016

An unannounced inspection by the Jiangsu Provincial Food and Drug Administration revealed significant quality management deficiencies at Nanjing Hongan Medical Technology Co., Ltd. The inspection report, published on May 9, 2016, detailed that the company's operational practices did not comply with the Good Manufacturing Practice for Medical Devices. These violations indicated a breakdown in their quality management systems, raising concerns about product quality and safety. As a result, Nanjing Hongan Medical Technology Co., Ltd. was ordered to immediately cease all production activities. Furthermore, the company was mandated to implement comprehensive corrective actions to rectify all identified deficiencies and achieve full compliance with the regulatory framework governing medical device manufacturing. This regulatory action emphasizes the importance of stringent adherence to manufacturing standards to ensure public health and safety in the medical device sector.